Stanley Appel - Publications

Affiliations: 
Duke University, Durham, NC 

161 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Zanotti-Fregonara P, Pascual B, Veronese M, Yu M, Beers D, Appel SH, Masdeu JC. Head-to-head comparison of C-PBR28 and C-ER176 for quantification of the translocator protein in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31152207 DOI: 10.1007/s00259-019-04349-w  0.36
2018 Zanotti-Fregonara P, Pascual B, Rizzo G, Yu M, Pal N, Beers D, Carter R, Appel S, Atassi N, Masdeu J. Head-to-head comparison of 11C-PBR28 and 18F-GE180 for the quantification of TSPO in the human brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29348317 DOI: 10.2967/jnumed.117.203109  0.36
2016 Appel SH, Armon C. Stem cells in amyotrophic lateral sclerosis: Ready for prime time? Neurology. PMID 27358334 DOI: 10.1212/WNL.0000000000002906  0.92
2016 Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, Ratti E, Atassi N, Boylan KB, Glass JD, Maragakis NJ, Caress JB, McCluskey LF, Appel SH, Wymer JP, et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27261500 DOI: 10.1136/jnnp-2016-313521  0.92
2015 Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, Ren Z, Keebler J, Han Y, Levy SE, Boone BE, ... ... Appel S, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science (New York, N.Y.). 347: 1436-41. PMID 25700176 DOI: 10.1126/science.aaa3650  0.92
2015 Hooten KG, Beers DR, Zhao W, Appel SH. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 364-75. PMID 25567201 DOI: 10.1007/s13311-014-0329-3  0.92
2015 Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH, Appel SH. TDP-43 activates microglia through NF-κB and NLRP3 inflammasome Experimental Neurology. 273: 24-35. DOI: 10.1016/j.expneurol.2015.07.019  0.92
2014 McElhiney M, Rabkin JG, Goetz R, Katz J, Miller RG, Forshew DA, David W, Cudkowicz M, Glass JD, Appel S, Simpson E, Mitsumoto H. Seeking a measure of clinically meaningful change in ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 15: 398-405. PMID 25124889 DOI: 10.3109/21678421.2014.942668  0.92
2014 Pattee GL, Wymer JP, Lomen-Hoerth C, Appel SH, Formella AE, Pope LE. An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions. Current Medical Research and Opinion. 30: 2255-65. PMID 25062507 DOI: 10.1185/03007995.2014.940040  0.92
2014 Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, Baloh RH, Ravits J, Simpson E, Appel SH, Pestronk A, Goate AM, Miller TM, Cruchaga C, Harms MB. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. Jama Neurology. 71: 449-53. PMID 24535663 DOI: 10.1001/jamaneurol.2013.6237  0.92
2014 McElhiney M, Rabkin JG, Goetz R, Katz J, Miller RG, Forshew DA, David W, Cudkowicz M, Glass JD, Appel S, Simpson E, Mitsumoto H. Correction to: 'Seeking a measure of clinically meaningful change in ALS' Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 627. DOI: 10.3109/21678421.2014.964589  0.92
2014 Appel SH, Beers DR, Zhao W. Role of Inflammation in Neurodegenerative Diseases Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. 380-395. DOI: 10.1016/B978-0-12-398270-4.00025-2  0.92
2014 Appel SH. Foreword Inflammation in Parkinson's Disease: Scientific and Clinical Aspects. vii-x. DOI: 10.1007/978-3-319-08046-8  0.92
2013 Appel SH. Special issue: A tribute to Jenny S. Henkel, Ph.D. (1955-2013). Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 757-1047. PMID 23900591 DOI: 10.1007/s11481-013-9492-2  0.92
2013 Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 888-99. PMID 23881705 DOI: 10.1007/s11481-013-9489-x  0.92
2013 Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, Floeter MK, Henderson C, Lomen-Hoerth C, Macklis JD, McCluskey L, Mitsumoto H, Przedborski S, Rothstein J, Trojanowski JQ, et al. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 5-18. PMID 23678876 DOI: 10.3109/21678421.2013.778548  0.92
2013 Miller TM, Pestronk A, David W, Rothstein J, Simpson E, Appel SH, Andres PL, Mahoney K, Allred P, Alexander K, Ostrow LW, Schoenfeld D, Macklin EA, Norris DA, Manousakis G, et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. The Lancet. Neurology. 12: 435-42. PMID 23541756 DOI: 10.1016/S1474-4422(13)70061-9  0.92
2013 Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, Zhao W, Moore DH, Powell SZ, Appel SH. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. Embo Molecular Medicine. 5: 64-79. PMID 23143995 DOI: 10.1002/emmm.201201544  0.92
2013 Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV. Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathologica. 125: 111-20. PMID 22941226 DOI: 10.1007/s00401-012-1039-8  0.92
2012 Appel SH, Rowland LP. Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62: a functional convergence? Neurology. 79: 1526-7. PMID 22972643 DOI: 10.1212/WNL.0b013e31826e26ec  0.92
2012 Zhao W, Beers DR, Liao B, Henkel JS, Appel SH. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiology of Disease. 48: 418-28. PMID 22820142 DOI: 10.1016/j.nbd.2012.07.008  0.92
2012 Appel SH. Inflammation in Parkinson's disease: cause or consequence? Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1075-7. PMID 22806694 DOI: 10.1002/mds.25111  0.92
2012 Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Experimental Neurology. 237: 147-52. PMID 22735487 DOI: 10.1016/j.expneurol.2012.06.011  0.92
2012 Kano O, Beers DR, Henkel JS, Appel SH. Peripheral nerve inflammation in ALS mice: cause or consequence. Neurology. 78: 833-5. PMID 22377817 DOI: 10.1212/WNL.0b013e318249f776  0.92
2012 Henkel JS, Beers DR, Zhao W, Appel SH. Reactive oxygen and nitrogen species - A driving force in amyotrophic lateral sclerosis Systems Biology of Free Radicals and Antioxidants. 3141-3165. DOI: 10.1007/978-3-642-30018-9_131  0.92
2011 Vaknin I, Kunis G, Miller O, Butovsky O, Bukshpan S, Beers DR, Henkel JS, Yoles E, Appel SH, Schwartz M. Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis. Plos One. 6: e26921. PMID 22073221 DOI: 10.1371/journal.pone.0026921  0.92
2011 Gendelman HE, Appel SH. Neuroprotective activities of regulatory T cells. Trends in Molecular Medicine. 17: 687-8. PMID 21996344 DOI: 10.1016/j.molmed.2011.08.005  0.92
2011 Appel SH, Zhao W, Beers DR, Henkel JS. The microglial-motoneuron dialogue in ALS. Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology / Edited by the Gaetano Conte Academy For the Study of Striated Muscle Diseases. 30: 4-8. PMID 21842586  0.92
2011 Miller RG, Moore DH, Forshew DA, Katz JS, Barohn RJ, Valan M, Bromberg MB, Goslin KL, Graves MC, McCluskey LF, McVey AL, Mozaffar T, Florence JM, Pestronk A, Ross M, ... ... Appel SH, et al. Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology. 77: 973-9. PMID 21813790 DOI: 10.1212/WNL.0b013e31822dc7a5  0.92
2011 Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, Liao B, Appel SH. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain : a Journal of Neurology. 134: 1293-314. PMID 21596768 DOI: 10.1093/brain/awr074  0.92
2011 Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, Appel SH, Henkel JS. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain, Behavior, and Immunity. 25: 1025-35. PMID 21176785 DOI: 10.1016/j.bbi.2010.12.008  0.92
2011 Jawaid A, Poon M, Strutt AM, Rice LK, McDowell EJ, Salamone AR, Qureshi SU, Simpson E, Appel SH, York MK, Schulz PE. Does apolipoprotein E genotype modify the clinical expression of ALS? European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: 618-24. PMID 20880000 DOI: 10.1111/j.1468-1331.2010.03225.x  0.92
2010 Appel SH, Cwik VA, Day JW. Trauma, TDP-43, and amyotrophic lateral sclerosis. Muscle & Nerve. 42: 851-2. PMID 21104858 DOI: 10.1002/mus.21939  0.92
2010 Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, Simpson E, Appel SH, York MK, Schulz PE. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 733-9. PMID 20074230 DOI: 10.1111/j.1468-1331.2009.02923.x  0.92
2010 Cudkowicz ME, Katz J, Moore DH, O'Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, et al. Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 259-65. PMID 19961263 DOI: 10.3109/17482960903358865  0.92
2010 Appel SH, Beers DR, Henkel JS. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Trends in Immunology. 31: 7-17. PMID 19879804 DOI: 10.1016/j.it.2009.09.003  0.92
2010 Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, Mosnik D, Appel SH, Schulz PE. Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 103-10. PMID 19874396 DOI: 10.1111/j.1468-1331.2009.02801.x  0.92
2010 Sterling LE, Jawaid A, Salamone AR, Murthy SB, Mosnik DM, McDowell E, Wheaton M, Strutt AM, Simpson E, Appel S, Schulz PE. Association between dysarthria and cognitive impairment in ALS: A prospective study. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 46-51. PMID 19722114 DOI: 10.3109/17482960903207997  0.92
2010 Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien JP, Appel SH. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia. 58: 231-43. PMID 19672969 DOI: 10.1002/glia.20919  0.92
2009 Howe CL, Bergstrom RA, Horazdovsky BF. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology. 73: 1247; author reply 1. PMID 19822878 DOI: 10.1212/WNL.0b013e3181b26ae6  0.92
2009 Henkel JS, Beers DR, Zhao W, Appel SH. Microglia in ALS: the good, the bad, and the resting. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 4: 389-98. PMID 19731042 DOI: 10.1007/s11481-009-9171-5  0.92
2009 Goldknopf IL, Bryson JK, Strelets I, Quintero S, Sheta EA, Mosqueda M, Park HR, Appel SH, Shill H, Sabbagh M, Chase B, Kaldjian E, Markopoulou K. Abnormal serum concentrations of proteins in Parkinson's disease. Biochemical and Biophysical Research Communications. 389: 321-7. PMID 19723509 DOI: 10.1016/j.bbrc.2009.08.150  0.92
2009 Hannibal MC, Ruzzo EK, Miller LR, Betz B, Buchan JG, Knutzen DM, Barnett K, Landsverk ML, Brice A, LeGuern E, Bedford HM, Worrall BB, Lovitt S, Appel SH, Andermann E, et al. SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy. Neurology. 72: 1755-9. PMID 19451530 DOI: 10.1212/WNL.0b013e3181a609e3  0.92
2009 Henkel JS, Beers DR, Wen S, Bowser R, Appel SH. Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology. 72: 1614-6. PMID 19414730 DOI: 10.1212/WNL.0b013e3181a41228  0.92
2009 Appel S, Barres B, Carlson K, Chernyshev A, Cox G, Fanara P, Gatchel J, Glass J, Johnson E, Johnstone B, Leitner M, Li Y, Lutz C, Ngo H, Perrin S, et al. Alzheimer research forum live discussion: Mice on trial? issues in the design of drug studies Journal of Alzheimer's Disease. 16: 197-205. PMID 19158436 DOI: 10.3233/JAD-2009-0961  0.92
2009 Appel SH. CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. The Journal of Clinical Investigation. 119: 13-5. PMID 19104142 DOI: 10.1172/JCI38096  0.92
2008 Sorenson EJ, Windbank AJ, Mandrekar JN, Bamlet WR, Appel SH, Armon C, Barkhaus PE, Bosch P, Boylan K, David WS, Feldman E, Glass J, Gutmann L, Katz J, King W, et al. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology. 71: 1770-5. PMID 19029516 DOI: 10.1212/01.wnl.0000335970.78664.36  0.92
2008 Appel SH, Engelhardt JI, Henkel JS, Siklos L, Beers DR, Yen AA, Simpson EP, Luo Y, Carrum G, Heslop HE, Brenner MK, Popat U. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology. 71: 1326-34. PMID 18936424 DOI: 10.1212/01.wnl.0000327668.43541.22  0.92
2008 Beers DR, Henkel JS, Zhao W, Wang J, Appel SH. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proceedings of the National Academy of Sciences of the United States of America. 105: 15558-63. PMID 18809917 DOI: 10.1073/pnas.0807419105  0.92
2008 Appel SH, Beers DR, Henkel JS, Zhao W. Novel therapeutic targets in neurodegenerative diseases: lessons from amyotrophic lateral sclerosis. Current Neurology and Neuroscience Reports. 8: 353-5. PMID 18713569 DOI: 10.1007/s11910-008-0054-6  0.92
2008 Villoslada P, Moreno B, Melero I, Pablos JL, Martino G, Uccelli A, Montalban X, Avila J, Rivest S, Acarin L, Appel S, Khoury SJ, McGeer P, Ferrer I, Delgado M, et al. Immunotherapy for neurological diseases. Clinical Immunology (Orlando, Fla.). 128: 294-305. PMID 18534912 DOI: 10.1016/j.clim.2008.04.003  0.92
2008 Voustianiouk A, Seidel G, Panchal J, Sivak M, Czaplinski A, Yen A, Appel SH, Lange DJ. ALSFRS and appel ALS scores: discordance with disease progression. Muscle & Nerve. 37: 668-72. PMID 18288708 DOI: 10.1002/mus.20977  0.92
2007 Wheaton MW, Salamone AR, Mosnik DM, McDonald RO, Appel SH, Schmolck HI, Ringholz GM, Schulz PE. Cognitive impairment in familial ALS. Neurology. 69: 1411-7. PMID 17909153 DOI: 10.1212/01.wnl.0000277422.11236.2c  0.92
2007 Miller R, Bradley W, Cudkowicz M, Hubble J, Meininger V, Mitsumoto H, Moore D, Pohlmann H, Sauer D, Silani V, Strong M, Swash M, Vernotica E, Cashman N, Eisen A, ... ... Appel S, et al. Phase II/III randomized trial of TCH346 in patients with ALS Neurology. 69: 776-784. PMID 17709710 DOI: 10.1212/01.wnl.0000269676.07319.09  0.92
2007 Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF, Stamper C, Jensen KR, Letizia D, Hesterlee SE, Pestronk A, Levine T, Bertorini T, Graves MC, ... ... Appel SH, et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. The New England Journal of Medicine. 357: 775-88. PMID 17671248 DOI: 10.1056/NEJMoa070174  0.92
2007 Xiao Q, Zhao W, Beers DR, Yen AA, Xie W, Henkel JS, Appel SH. Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. Journal of Neurochemistry. 102: 2008-19. PMID 17555556 DOI: 10.1111/j.1471-4159.2007.04677.x  0.92
2007 Czaplinski A, Yen AA, Simpson EP, Appel SH. In reply [5] Archives of Neurology. 64: 459.  0.92
2006 Czaplinski A, Haverkamp LJ, Yen AA, Simpson EP, Lai EC, Appel SH. The value of database controls in pilot or futility studies in ALS. Neurology. 67: 1827-32. PMID 17130417 DOI: 10.1212/01.wnl.0000244415.48221.81  0.92
2006 Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 103: 16021-6. PMID 17043238 DOI: 10.1073/pnas.0607423103  0.92
2006 Zhao W, Xie W, Xiao Q, Beers DR, Appel SH. Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. Journal of Neurochemistry. 99: 1176-87. PMID 17018025 DOI: 10.1111/j.1471-4159.2006.04172.x  0.92
2006 Czaplinski A, Yen AA, Simpson EP, Appel SH. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle & Nerve. 34: 702-8. PMID 16967489 DOI: 10.1002/mus.20658  0.92
2006 Czaplinski A, Yen AA, Simpson EP, Appel SH. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? Archives of Neurology. 63: 1139-43. PMID 16908741 DOI: 10.1001/archneur.63.8.1139  0.92
2006 Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. Journal of Neurology. 253: 1428-36. PMID 16773270 DOI: 10.1007/s00415-006-0226-8  0.92
2006 Goldknopf IL, Sheta EA, Bryson J, Folsom B, Wilson C, Duty J, Yen AA, Appel SH. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochemical and Biophysical Research Communications. 342: 1034-9. PMID 16516157 DOI: 10.1016/j.bbrc.2006.02.051  0.92
2006 Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 390-2. PMID 16484652 DOI: 10.1136/jnnp.2005.072660  0.92
2006 Appel SH. Is ALS a systemic disorder? Evidence from muscle mitochondria. Experimental Neurology. 198: 1-3. PMID 16458887 DOI: 10.1016/j.expneurol.2005.12.025  0.92
2006 Sheta EA, Appel SH, Goldknopf IL. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases. Expert Review of Proteomics. 3: 45-62. PMID 16445350 DOI: 10.1586/14789450.3.1.45  0.92
2006 Henkel JS, Beers DR, Siklós L, Appel SH. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Molecular and Cellular Neurosciences. 31: 427-37. PMID 16337133 DOI: 10.1016/j.mcn.2005.10.016  0.92
2006 Czaplinski A, Appel SH. Amyotrophic lateral sclerosis: Can we predict the course of disease? Schweizer Archiv Fur Neurologie Und Psychiatrie. 157: 317-322.  0.92
2005 Yoshor D, Klugh A, Appel SH, Haverkamp LJ. Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosis. Neurosurgery. 57: 984-9; discussion 98. PMID 16284567 DOI: 10.1227/01.NEU.0000180028.64385.d3  0.92
2005 Mitsumoto H, Bromberg M, Johnston W, Tandan R, Byock I, Lyon M, Miller RG, Appel SH, Benditt J, Bernat JL, Borasio GD, Carver AC, Clawson L, Del Bene ML, Kasarskis EJ, et al. Promoting excellence in end-of-life care in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 6: 145-54. PMID 16183556 DOI: 10.1080/14660820510028647  0.92
2005 Simpson EP, Appel SH. "Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers" by Lo Coco G, Lo Coco D, Cicero V, Oliveri A, Lo Verso G, Piccolo F, La Bella V. Journal of the Neurological Sciences. 238: 1-2. PMID 16125725 DOI: 10.1016/j.jns.2005.06.010  0.92
2005 Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 65: 586-90. PMID 16116120 DOI: 10.1212/01.wnl.0000172911.39167.b6  0.92
2005 Das A, Sribnick EA, Wingrave JM, Del Re AM, Woodward JJ, Appel SH, Banik NL, Ray SK. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. Journal of Neuroscience Research. 81: 551-62. PMID 15968645 DOI: 10.1002/jnr.20581  0.92
2005 Vigh L, Smith RG, Soós J, Engelhardt JI, Appel SH, Siklós L. Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in vivo. Acta Neuropathologica. 109: 567-75. PMID 15933871 DOI: 10.1007/s00401-004-0977-1  0.92
2005 Siklós L, Appel SH. Calcium binding proteins in selective vulnerability of motor neurons Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics. 65-79. DOI: 10.1017/CBO9780511544873.007  0.92
2004 Appel SH. Euthanasia and physician-assisted suicide in ALS: a commentary. The American Journal of Hospice & Palliative Care. 21: 405-6. PMID 15612229  0.92
2004 Yen A, Simpson E, Haverkamp L, Appel S. AALSS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 94-8. PMID 15512884 DOI: 10.1080/17434470410019708  0.92
2004 Yen A, Simpson E, Haverkamp L, Appel S. Design using historical controls. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 61-3. PMID 15512876 DOI: 10.1080/17434470410019807  0.92
2004 Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, Pope LE, Smith RA. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 63: 1364-70. PMID 15505150  0.92
2004 Zhao W, Xie W, Le W, Beers DR, He Y, Henkel JS, Simpson EP, Yen AA, Xiao Q, Appel SH. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. Journal of Neuropathology and Experimental Neurology. 63: 964-77. PMID 15453095  0.92
2004 Koh SH, Kwon H, Kim KS, Kim J, Kim MH, Yu HJ, Kim M, Lee KW, Do BR, Jung HK, Yang KW, Appel SH, Kim SH. Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals. Toxicology. 202: 213-25. PMID 15337584 DOI: 10.1016/j.tox.2004.05.008  0.92
2004 Trail M, Nelson N, Van JN, Appel SH, Lai EC. Major stressors facing patients with amyotrophic lateral sclerosis (ALS): a survey to identify their concerns and to compare with those of their caregivers. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 40-5. PMID 15204023 DOI: 10.1080/14660820310016075  0.92
2004 Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology. 62: 1758-65. PMID 15159474  0.92
2004 Yen AA, Simpson EP, Henkel JS, Beers DR, Appel SH. HFE mutations are not strongly associated with sporadic ALS. Neurology. 62: 1611-2. PMID 15136693  0.92
2004 Le W, Appel SH. Mutant genes responsible for Parkinson's disease. Current Opinion in Pharmacology. 4: 79-84. PMID 15018843 DOI: 10.1016/j.coph.2003.09.005  0.92
2004 Henkel JS, Engelhardt JI, Siklós L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Annals of Neurology. 55: 221-35. PMID 14755726 DOI: 10.1002/ana.10805  0.92
2004 Kim SH, Engelhardt JI, Henkel JS, Siklós L, Soós J, Goodman C, Appel SH. Widespread increased expression of the DNA repair enzyme PARP in brain in ALS. Neurology. 62: 319-22. PMID 14745081  0.92
2003 Simpson EP, Yen AA, Appel SH. Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Current Opinion in Rheumatology. 15: 730-6. PMID 14569202 DOI: 10.1097/00002281-200311000-00008  0.92
2003 Sengun IS, Appel SH. Serum anti-Fas antibody levels in amyotrophic lateral sclerosis. Journal of Neuroimmunology. 142: 137-40. PMID 14512172 DOI: 10.1016/S0165-5728(03)00263-7  0.92
2003 Nelson ND, Trail M, Van JN, Appel SH, Lai EC. Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics. Journal of Palliative Medicine. 6: 417-24. PMID 14509487 DOI: 10.1089/109662103322144736  0.92
2003 He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, Appel SH, Le W. Role of nitric oxide in rotenone-induced nigro-striatal injury. Journal of Neurochemistry. 86: 1338-45. PMID 12950443 DOI: 10.1046/j.1471-4159.2003.01938.x  0.92
2003 Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH, Johnson H, Qureshi M, Jacobs M, Rothstein JD, Appel SH, Pascuzzi RM, Heiman-Patterson TD, Donofrio PD, David WS, Russell JA, Tandan R, et al. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology. 61: 456-64. PMID 12939417  0.92
2003 Trail M, Nelson ND, Van JN, Appel SH, Lai EC. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. Journal of the Neurological Sciences. 209: 79-85. PMID 12686407 DOI: 10.1016/S0022-510X(03)00003-0  0.92
2003 Kim SH, Henkel JS, Beers DR, Sengun IS, Simpson EP, Goodman JC, Engelhardt JI, Siklós L, Appel SH. PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. Journal of Neuropathology and Experimental Neurology. 62: 88-103. PMID 12528821  0.92
2003 Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK. Mutations in NR4A2 associated with familial Parkinson disease. Nature Genetics. 33: 85-9. PMID 12496759 DOI: 10.1038/ng1066  0.92
2003 Borasio GD, Appel SH. Upper and Lower Motor Neuron Disorders Neurological Disorders: Course and Treatment: Second Edition. 1165-1176. DOI: 10.1016/B978-012125831-3/50276-8  0.92
2002 He Y, Le WD, Appel SH. Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Experimental Neurology. 176: 322-7. PMID 12359173 DOI: 10.1006/exnr.2002.7946  0.92
2002 Mohamed HA, Mosier DR, Zou LL, Siklós L, Alexianu ME, Engelhardt JI, Beers DR, Le WD, Appel SH. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. Journal of Neuroscience Research. 69: 110-6. PMID 12111822 DOI: 10.1002/jnr.10271  0.92
2002 Simpson EP, Mosier D, Appel SH. Mechanisms of disease pathogenesis in amyotrophic lateral sclerosis. A central role for calcium. Advances in Neurology. 88: 1-19. PMID 11908220  0.92
2001 Appel SH, Simpson EP. Activated microglia: the silent executioner in neurodegenerative disease? Current Neurology and Neuroscience Reports. 1: 303-5. PMID 11898534  0.92
2001 Beers DR, Ho BK, Siklós L, Alexianu ME, Mosier DR, Mohamed AH, Otsuka Y, Kozovska ME, McAlhany RE, Smith RG, Appel SH. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. Journal of Neurochemistry. 79: 499-509. PMID 11701753 DOI: 10.1046/j.1471-4159.2001.00582.x  0.92
2001 Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 57: 1282-9. PMID 11591849  0.44
2001 Appel SH, Beers D, Siklos L, Engelhardt JI, Mosier DR. Calcium: the Darth Vader of ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 2: S47-54. PMID 11465925  0.92
2001 Bodamer OA, Rosenblatt DS, Appel SH, Beaudet AL. Adult-onset combined methylmalonic aciduria and homocystinuria (cblC). Neurology. 56: 1113. PMID 11320193  0.92
2000 Smith RG, Appel SH. Immunosuppression and anti-inflammatory agents in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 1: 33-42; discussion 42. PMID 11466958 DOI: 10.1080/14660820050515692-1  0.92
2000 Appel SH, Beers D, Smith RG, Wilson JE. Altered calcium homeostasis in ALS as a target for therapy. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 1: 27-32. PMID 11466956  0.44
2000 Engelhardt JI, Le WD, Siklós L, Obál I, Boda K, Appel SH. Stereotaxic injection of IgG from patients with Alzheimer disease initiates injury of cholinergic neurons of the basal forebrain. Archives of Neurology. 57: 681-6. PMID 10815134  0.4
2000 Siklós L, Engelhardt JI, Reaume AG, Scott RW, Adalbert R, Obál I, Appel SH. Altered calcium homeostasis in spinal motoneurons but not in oculomotor neurons of SOD-1 knockout mice. Acta Neuropathologica. 99: 517-24. PMID 10805095  0.4
2000 Alexianu ME, Manole E, Engelhardt JI, Appel SH. Ultrastructural evidence of calcium involvement in experimental autoimmune gray matter disease. Journal of Neuroscience Research. 60: 98-105. PMID 10723072 DOI: 10.1002/(SICI)1097-4547(20000401)60:1<98::AID-JNR10>3.0.CO;2-B  0.44
2000 Mosier DR, Siklós L, Appel SH. Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera. Neurology. 54: 252-5. PMID 10636164  0.92
2000 Ojika K, Mitake S, Tohdoh N, Appel SH, Otsuka Y, Katada E, Matsukawa N. Hippocampal cholinergic neurostimulating peptides (HCNP). Progress in Neurobiology. 60: 37-83. PMID 10622376 DOI: 10.1016/S0301-0082(99)00021-0  0.92
1999 Siklós L, Engelhardt JI, Adalbert R, Appel SH. Calcium-containing endosomes at oculomotor terminals in animal models of ALS. Neuroreport. 10: 2539-45. PMID 10574366  0.4
1999 Le W, Conneely OM, Zou L, He Y, Saucedo-Cardenas O, Jankovic J, Mosier DR, Appel SH. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Experimental Neurology. 159: 451-8. PMID 10506516 DOI: 10.1006/exnr.1999.7191  0.92
1999 Baskin DS, Browning JL, Pirozzolo FJ, Korporaal S, Baskin JA, Appel SH. Brain choline acetyltransferase and mental function in Alzheimer disease. Archives of Neurology. 56: 1121-3. PMID 10488813 DOI: 10.1001/archneur.56.9.1121  0.92
1998 Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Annals of Neurology. 44: 819-24. PMID 9818940 DOI: 10.1002/ana.410440518  0.44
1998 Smith RG, Henry YK, Mattson MP, Appel SH. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Annals of Neurology. 44: 696-9. PMID 9778272 DOI: 10.1002/ana.410440419  0.44
1998 Rowe DB, Le W, Smith RG, Appel SH. Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation. Journal of Neuroscience Research. 53: 551-8. PMID 9726426 DOI: 10.1002/(SICI)1097-4547(19980901)53:5<551::AID-JNR5>3.0.CO;2-8  0.44
1998 Chen S, Le WD, Xie WJ, Alexianu ME, Engelhardt JI, Siklós L, Appel SH. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Archives of Neurology. 55: 1075-80. PMID 9708957  0.44
1998 Siklós L, Engelhardt JI, Alexianu ME, Gurney ME, Siddique T, Appel SH. Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. Journal of Neuropathology and Experimental Neurology. 57: 571-87. PMID 9630237  0.92
1998 Colom LV, Diaz ME, Beers DR, Neely A, Xie WJ, Appel SH. Role of potassium channels in amyloid-induced cell death. Journal of Neurochemistry. 70: 1925-34. PMID 9572276  0.92
1998 Alexianu ME, Robbins E, Carswell S, Appel SH. 1Alpha, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motoneuron cells. Journal of Neuroscience Research. 51: 58-66. PMID 9452309 DOI: 10.1002/(SICI)1097-4547(19980101)51:1<58::AID-JNR6>3.0.CO;2-K  0.44
1998 Lange DJ, Murphy PL, Diamond B, Appel V, Lai EC, Younger DS, Appel SH. Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis. Archives of Neurology. 55: 93-6. PMID 9443715 DOI: 10.1001/archneur.55.1.93  0.92
1997 Colom LV, Neely A, Diaz ME, Xie WJ, Appel SH. Modulation of septal cell activity by extracellular zinc. Neuroreport. 8: 3081-6. PMID 9331918  0.92
1997 Engelhardt JI, Siklós L, Appel SH. Immunization of guinea pigs with human choline acetyltransferase induces selective lower motoneuron destruction. Journal of Neuroimmunology. 78: 57-68. PMID 9307228  0.4
1997 Colom LV, Alexianu ME, Mosier DR, Smith RG, Appel SH. Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line. Experimental Neurology. 146: 354-60. PMID 9270044 DOI: 10.1006/exnr.1997.6541  0.92
1997 Kálmán J, Engelhardt JI, Le WD, Xie W, Kovacs I, Kása P, Appel SH. Experimental immune-mediated damage of septal cholinergic neurons. Journal of Neuroimmunology. 77: 63-74. PMID 9209270  0.4
1997 La Bella V, Goodman JC, Appel SH. Increased CSF glutamate following injection of ALS immunoglobulins. Neurology. 48: 1270-2. PMID 9153455  0.92
1997 Engelhardt JI, Siklos L, Appel SH. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. Journal of Neuropathology and Experimental Neurology. 56: 21-39. PMID 8990126  0.4
1996 Siklós L, Engelhardt J, Harati Y, Smith RG, Joó F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Annals of Neurology. 39: 203-16. PMID 8967752 DOI: 10.1002/ana.410390210  0.44
1996 Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 61: 450-5. PMID 8937336  0.92
1996 Smith RG, Siklos L, Alexianu ME, Engelhardt JI, Mosier DR, Colom L, Habib Mohamed A, Appel SH. Autoimmunity and ALS. Neurology. 47: S40-5; discussion S4. PMID 8858050  0.92
1996 La Bella V, Alexianu ME, Colom LV, Ionescu A, Mohamed AH, Appel SH. Apoptosis induced by beta-N-oxalylamino-L-alanine on a motoneuron hybrid cell line. Neuroscience. 70: 1039-52. PMID 8848166 DOI: 10.1016/0306-4522(95)00401-7  0.92
1996 La Bella V, Ho BK, Appel SH, Smith RG. Calbindin D28K forms a Ca(2+)-dissociable complex with mellitin in vitro. Biochemistry and Molecular Biology International. 38: 1199-210. PMID 8739042  0.44
1996 Smith RG, Haverkamp LJ, Case S, Appel V, Appel SH. Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease. Lancet. 348: 334-5. PMID 8709704  0.44
1996 Ho BK, Alexianu ME, Colom LV, Mohamed AH, Serrano F, Appel SH. Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 93: 6796-801. PMID 8692898  0.92
1996 Appel SH, Smith RG, Le WD. Immune-mediated cell death in neurodegenerative disease. Advances in Neurology. 69: 153-9. PMID 8615124  0.44
1995 Mosier DR, Baldelli P, Delbono O, Smith RG, Alexianu ME, Appel SH, Stefani E. Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line. Annals of Neurology. 37: 102-9. PMID 7818241 DOI: 10.1002/ana.410370119  0.92
1995 Le W, Xie WJ, Nyormoi O, Ho BK, Smith RG, Appel SH. beta-Amyloid1-40 increases expression of beta-amyloid precursor protein in neuronal hybrid cells. Journal of Neurochemistry. 65: 2373-6. PMID 7595528  0.44
1995 Le WD, Colom LV, Xie WJ, Smith RG, Alexianu M, Appel SH. Cell death induced by beta-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Research. 686: 49-60. PMID 7583271 DOI: 10.1016/0006-8993(95)00450-5  0.92
1995 Schneider T, Perez-Reyes E, Nyormoi O, Wei X, Crawford GD, Smith RG, Appel SH, Birnbaumer L. Alpha-1 subunits of voltage gated Ca2+ channels in the mesencephalon x neuroblastoma hybrid cell line MES23.5. Neuroscience. 68: 479-85. PMID 7477958 DOI: 10.1016/0306-4522(95)00147-B  0.92
1977 McNamara JO, Appel SH. Biochemical approaches to dementia. Contemporary Neurology Series. 15: 155-68. PMID 144584  0.92
1977 McNamara JO, Appel SH. Myelin basic protein phosphatase activity in rat brain. Journal of Neurochemistry. 29: 27-35. PMID 69679  0.92
1976 Roses AD, Roses MJ, Miller SE, Hull KL, Appel SH. Carrier detection in Duchenne muscular dystrophy. The New England Journal of Medicine. 294: 193-8. PMID 1244534 DOI: 10.1056/NEJM197601222940404  0.92
1976 Roses AD, Appel SH. Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy. Journal of the Neurological Sciences. 29: 185-93. PMID 978207 DOI: 10.1016/0022-510X(76)90170-2  0.92
1976 Butterfield DA, Roses AD, Appel SH, Chesnut DB. Electron spin resonance studies of membrane proteins in erythrocytes in myotonic muscular dystrophy. Archives of Biochemistry and Biophysics. 177: 226-34. PMID 187121 DOI: 10.1016/0003-9861(76)90432-X  0.92
1976 Butterfield DA, Chesnut DB, Appel SH, Roses AD. Spin label study of erythrocyte membrane fluidity in myotonic and Duchenne muscular dystrophy and congenital myotonia. Nature. 263: 159-61. PMID 184394 DOI: 10.1038/263159a0  0.92
1976 Roses AD, Herbstreith M, Metcalf B, Appel SH. Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne muscular dystrophy. Journal of the Neurological Sciences. 30: 167-78. PMID 10352  0.76
1976 Miller SE, Roses AD, Appel SH. Scanning electron microscopy studies in muscular dystrophy. Archives of Neurology. 33: 172-4. PMID 3154  0.76
1975 Miller SE, Roses AD, Appel SH. Letter: Erythrocytes in human muscular dystrophy. Science (New York, N.Y.). 188: 1131. PMID 1215993  0.76
1975 Roses AD, Herbstreith MH, Appel SH. Membrane protein kinase alteration in Duchenne muscular dystrophy. Nature. 254: 350-1. PMID 1118019  0.76
1975 Roses AD, Appel SH, Butterfield DA, Miller SE, Chesnut DB. Specificity of biochemical and biophysical tests in Duchenne and myotonic muscular dystrophy, carrier states, and congenital myotonia. Transactions of the American Neurological Association. 100: 131-4. PMID 179179  0.92
1975 Roses AD, Butterfield A, Appel SH, Chestnut DB. Phenytoin and membrane fluidity in myotonic dystrophy. Archives of Neurology. 32: 535-8. PMID 168843  0.76
1975 Roses AD, Appel SH. Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy. The Journal of Membrane Biology. 20: 51-8. PMID 123592 DOI: 10.1007/BF01870627  0.92
1974 Butterfield DA, Roses AD, Cooper ML, Appel SH, Chesnut DB. A comparative electron spin resonance study of the erythrocyte membrane in myotonic muscular dystrophy. Biochemistry. 13: 5078-82. PMID 4373028  0.92
1974 Butterfield DA, Chesnut DB, Roses AD, Appel SH. Electron spin resonance studies of erythrocytes from patients with myotonic muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 71: 909-13. PMID 4362637  0.92
1974 Roses AD, Appel SH. Muscle membrane protein kinase in myotonic muscular dystrophy. Nature. 250: 245-7. PMID 4277586 DOI: 10.1038/250245a0  0.92
1974 Roses AD, Appel SH. Letter: Muscular dystrophies. Lancet (London, England). 2: 1400. PMID 4143368  0.92
1973 Andrew CG, Roses AD, Almon RR, Appel SH. Phosphorylation of muscle membranes: identification of a membrane-bound protein kinase. Science (New York, N.Y.). 182: 927-9. PMID 4355523  0.76
1973 Roses AD, Appel SH. Protein kinase activity in erythrocyte ghosts of patients with myotonic muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 70: 1855-9. PMID 4352659  0.92
1973 Roses AD, Appel SH. Erythrocyte protein phosphorylation. The Journal of Biological Chemistry. 248: 1408-11. PMID 4346955  0.92
Show low-probability matches.